Centessa Pharmaceuticals: Q1 Earnings Insights

Comments
Loading...

Centessa Pharmaceuticals CNTA reported its Q1 earnings results on Friday, May 12, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Centessa Pharmaceuticals missed estimated earnings by 60.61%, reporting an EPS of $-0.53 versus an estimate of $-0.33.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 1.28% drop in the share price the next day.

To track all earnings releases for Centessa Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

CNTA Logo
CNTACentessa Pharmaceuticals PLC
$11.943.20%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
34.12
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: